Disomy 21 in spermatozoa and the paternal origin of trisomy 21 Down syndrome

Molecular Cytogenetics

Maj A. Hultén¹  Ulrik Kvist²  Erik Iwarsson¹ 

[1] Department of Clinical Genetics, Karolinska University Hospital, Stockholm, S-171 76, Sweden;Centre for Andrology and Sexual Medicine, Karolinska University Hospital Huddinge, Stockholm, S-141 86, Sweden

关键词: Paternal origin;    Disomy 21;    Fluorescence in situ hybridisation (FISH);    Chromosome copy number;    Spermatozoa;    Down syndrome;    Trisomy 21;   

Others  :  1224152
DOI  :  10.1186/s13039-015-0155-2

 received in 2015-05-29, accepted in 2015-06-29,  发布年份 2015

【 摘 要 】

Background

Trisomy 21 Down syndrome is the most common genetic cause for congenital malformations and intellectual disability. It is well known that in the outstanding majority of cases the extra chromosome 21 originates from the mother but only in less than 10 % from the father. The mechanism underlying this striking difference in parental origin of Trisomy 21 Down syndrome is still unknown. However, it seems likely that the main reason is a much higher stringency in the elimination of any trisomy 21 cells during fetal testicular than ovarian development. We have here focussed attention on the paternal gametic output, i.e. the incidence of disomy 21 in spermatozoa.

Results

We have used fluorescence in situ hybridisation (FISH) to determine the copy number of chromosome 21 in spermatozoa from 11 men with normal spermiograms. Due to the well-known risk of false positive and false negative signals using a single FISH probe, we have applied two chromosome 21q probes, and we have added a chromosome 18-specific probe to allow differentiation between disomy 21 and diploidy. Analysing a total number of 2000 spermatozoa per case, we documented an average incidence of disomy 21 at 0.13 %, with a range of 0.00-0.25 % and a SD of 0.08. There was no indication of diploidy in this cohort of 22,000 sperm.

Conclusion

Numerous previous studies on the incidence of disomy 21 in sperm have been published, using FISH. As far as we are aware, none of these have applied more than a single chromosome 21-specific probe. Accepting our mean of 0.13 % of disomy 21, and providing there is no selective fertilisation capability of disomy 21 sperm in relation to the normal, we conclude that around 1 in 800 conceptions is expected to be trisomic for chromosome 21 of paternal origin. Bearing in mind that the maternal origin likely is at least 10 times more common, we tentatively propose that around 1 in 80 oocytes in the maternal ovarian reserve may be disomy 21. One reason for this discrepancy may be a more stringent selection against aberrant chromosome numbers during spermatogenesis than oogenesis. Further work is required to determine the relevant stages of spermatogenesis at which such a selection may take place.

【 授权许可】

   
2015 Iwarsson et al.

【 图 表 】

Fig. 1.

【 参考文献 】

• [1]Morris JK, Alberman E, Mutton D, Jacobs P. Cytogenetic and epidemiological findings in Down syndrome: England and Wales 1989-2009. Am J Med Genet A. 2012;158a(5):1151-7. doi:10.1002/ajmg.a.35248.
• [2]Hultén MA, Patel S, Jonasson J, Iwarsson E. On the origin of the maternal age effect in trisomy 21 Down syndrome: the Oocyte Mosaicism Selection model. Reproduction. 2010; 139(1):1-9.
• [3]Herbert M, Kalleas D, Cooney D, Lamb M, Lister L. Meiosis and Maternal Aging: Insights from Aneuploid Oocytes and Trisomy Births. Cold Spring Harb Perspect Biol. 2015; 7(4):a017970.
• [4]Kurahashi H, Tsutsumi M, Nishiyama S, Kogo H, Inagaki H, Ohye T. Molecular basis of maternal age-related increase in oocyte aneuploidy. Congenit Anom. 2012; 52(1):8-15.
• [5]Rowsey R, Kashevarova A, Murdoch B, Dickenson C, Woodruff T, Cheng E et al.. Germline mosaicism does not explain the maternal age effect on trisomy. Am J Med Genet A. 2013; 161(10):2495-2503.
• [6]Hultén M, Öijerstedt L, Iwarsson E, Jonasson J. Maternal Germinal Trisomy 21 in Down Syndrome. J Clin Med. 2014; 3(1):167-175.
• [7]Hultén MA, Patel SD, Tankimanova M, Westgren M, Papadogiannakis N, Jonsson AM et al.. On the origin of trisomy 21 Down syndrome. Mol Cytogenet. 2008; 1(1):21. BioMed Central Full Text
• [8]Hultén MA, Patel SD, Westgren M, Papadogiannakis N, Jonsson AM, Jonasson J et al.. On the paternal origin of trisomy 21 Down syndrome. Mol Cytogenet. 2010; 3:4. BioMed Central Full Text
• [9]Uroz L, Templado C. Meiotic non-disjunction mechanisms in human fertile males. Hum Reprod. 2012; 27(5):1518-1524.
• [10]Templado C, Uroz L, Estop A. New insights on the origin and relevance of aneuploidy in human spermatozoa. Mol Hum Reprod. 2013; 19(10):634-643.
• [11]Hultén MA, Dhanjal S, Pertl B. Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCR. Reproduction. 2003; 126(3):279-297.
• [12]Iourov IY, Vorsanova SG, Yurov YB. Intercellular Genomic (Chromosomal) Variations Resulting in Somatic Mosaicism: Mechanisms and Consequences. Curr Genomics. 2006; 7:435-446.
• [13]Vorsanova SG, Yurov YB, Iourov IY. Human interphase chromosomes: a review of available molecular cytogenetic technologies. Mol Cytogenet. 2010; 3:1. BioMed Central Full Text
• [14]Tempest HG. Meiotic recombination errors, the origin of sperm aneuploidy and clinical recommendations. Syst Biol Reprod Med. 2011; 57(1-2):93-101.
• [15]Tempest HG, Ko E, Rademaker A, Chan P, Robaire B, Martin RH. Intra-individual and inter-individual variations in sperm aneuploidy frequencies in normal men. Fertil Steril. 2009; 91(1):185-192.
• [16]Martin RH. Meiotic errors in human oogenesis and spermatogenesis. Reprod Biomed Online. 2008; 16(4):523-531.
• [17]Uroz L, Liehr T, Mrasek K, Templado C. Centromere-specific multicolour fluorescence in situ hybridization on human spermatocyte I and II metaphases. Hum Reprod. 2009; 24(8):2029-2033.
• [18]Laurie DA, Firkett CL, Hultén MA. A direct cytogenetic technique for assessing the rate of first meiotic non-disjunction in the human male by the analysis of cells at metaphase II. Ann Hum Genet. 1985; 49(Pt 1):23-29.
• [19]De Souza E, Alberman E, Morris JK. Down syndrome and paternal age, a new analysis of case-control data collected in the 1960s. Am J Med Genet A. 2009; 149A(6):1205-1208.
• [20]Fonseka KG, Griffin DK. Is there a paternal age effect for aneuploidy? Cytogenet Genome Res. 2011; 133(2-4):280-291.
• [21]Choi SK, Yoon SR, Calabrese P, Arnheim N. Positive Selection for New Disease Mutations in the Human Germline: Evidence from the Heritable Cancer Syndrome Multiple Endocrine Neoplasia Type 2B. PLoS Genet. 2012; 8(2): Article ID e1002420
• [22]Crow JF. Upsetting the dogma: germline selection in human males. PLoS Genet. 2012; 8(2): Article ID e1002535
• [23]Gazvani MR, Wilson ED, Richmond DH, Howard PJ, Kingsland CR, Lewis-Jones DI. Role of mitotic control in spermatogenesis. Fertil Steril. 2000; 74(2):251-256.
• [24]Jacobs PA. The chromosome complement of human gametes. Oxf Rev Reprod Biol. 1992; 14:47-72.
• [25]Rubes J, Vozdova M, Oracova E, Perreault SD. Individual variation in the frequency of sperm aneuploidy in humans. Cytogenet Genome Res. 2005; 111(3-4):229-236.